Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.48 USD | -1.62% | -3.52% | -3.01% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
Financials (USD)
Sales 2024 * | 25.7M | Sales 2025 * | 20.24M | Capitalization | 377M |
---|---|---|---|---|---|
Net income 2024 * | -116M | Net income 2025 * | -149M | EV / Sales 2024 * | 3.1 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 286M | EV / Sales 2025 * | 4.49 x |
P/E ratio 2024 * |
-3.41
x | P/E ratio 2025 * |
-2.88
x | Employees | 145 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.26% |
Latest transcript on C4 Therapeutics, Inc.
1 day | -1.62% | ||
1 week | -3.52% | ||
Current month | -13.02% | ||
1 month | -11.18% | ||
3 months | -42.38% | ||
6 months | +258.17% | ||
Current year | -3.01% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 20-09-13 |
Kendra Adams
DFI | Director of Finance/CFO | 48 | 20-11-19 |
Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 15-11-30 |
Glenn Dubin
BRD | Director/Board Member | 67 | 21-03-11 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 15-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 1,487 M€ | +8.80% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 5.48 | -1.62% | 773,892 |
24-05-23 | 5.57 | -3.97% | 1,155,851 |
24-05-22 | 5.8 | +0.69% | 787,448 |
24-05-21 | 5.76 | +2.49% | 891,124 |
24-05-20 | 5.62 | -1.06% | 876,082 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.01% | 377M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.87% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- CCCC Stock